PharmaCielo (TSXV:PCLO) Treasury Stock : C$0.00 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. PharmaCielo's treasury stock for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

PharmaCielo Treasury Stock Historical Data

The historical data trend for PharmaCielo's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Treasury Stock Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Treasury Stock

Get a 7-Day Free Trial

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

PharmaCielo Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

PharmaCielo (TSXV:PCLO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan

Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines